Authorization

Angion Announces Key Addition to Management Team and Appointments to Board of Directors

Appoints Jennifer J. Rhodes as Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary
- - -Strengthens the Board of Directors with the addition of industry leaders Dr. Allen R. Nissenson, Dr. Gilbert S. Omenn, and Karen J. WilsonSAN FRANCISCO, June 04, 2020 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (Angion), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, today announced the appointment of Ms. Jennifer J. Rhodes as Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary. Additionally, Allen R. Nissenson, M.D., Gilbert S. Omenn, M.D., Ph.D., and Karen J. Wilson have joined the Companya??s Board of Directors.Dr. Jay Venkatesan, Angiona??s President and Chief Executive Officer, said, a??We are excited to welcome Ms. Rhodes as our general counsel. She brings a wealth of in-house biopharmaceutical legal experience to help guide Angion into its next phase of growth.a??
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Декабрь 2020    »
ПнВтСрЧтПтСбВс
 123456
78910111213
14151617181920
21222324252627
28293031